Jinan KingMed

Guangzhou KingMed Medical Diagnostics Group Co., Ltd. [Stock Code: 603882] is a high-tech service enterprise centered on third-party medical testing and pathological diagnosis. It has established 49 medical laboratories, over 750 co-built laboratories, and a nationwide remote pathology collaboration network in mainland China, Hong Kong, and Macau. KingMed offers over 3,800 medical testing and pathological diagnosis items, providing "full lifecycle, full disease coverage, and full diagnosis and treatment management" medical testing and pathological diagnosis services to over 23,000 medical institutions nationwide. Its service network covers regions populated by over 90% of the national population, extending high-quality medical testing services to townships and communities, actively meeting the precise testing needs of primary-level and even remote frontline clinics, making medical testing more accessible and affordable. Jinan KingMed Medical Testing Center was established in 2007 as the group's first subsidiary, and is the first independent medical laboratory in Shandong Province to receive ISO15189 accreditation. It serves 15 cities across the province, with over 1,000 clients, independently conducting over 2,000 testing items, and processing 6 million specimens annually.